1. Written guidelines and protocols developed by a registered pharmacist in collaboration with a practitioner which authorize collaborative drug therapy management must include, without limitation: (a) A description of the types of decisions concerning the management of drug therapy that the pharmacist is authorized to make, including, without limitation: (1) A specific description of the diseases, drugs and categories of drugs covered by the guidelines; and (2) The types of decisions that the pharmacist is authorized to make for each disease, drug or category of drugs; (b) The training that the pharmacist is required to complete; (c) The procedures that the pharmacist is required to follow when initiating or modifying drug therapy or making other therapeutic decisions, including, without limitation: (1) Criteria that the pharmacist is required to use when making therapeutic decisions; and (2) Procedures for documenting therapeutic decisions and reporting such decisions to the practitioner; and (d) Procedures for the practitioner to provide feedback concerning therapeutic decisions to each pharmacist who is a party to the agreement. 2. s and reporting such decisions to the practitioner; and (d) Procedures for the practitioner to provide feedback concerning therapeutic decisions to each pharmacist who is a party to the agreement. 2. The Board may adopt regulations which prescribe additional requirements for written guidelines and protocols developed pursuant to this section. (Added to NRS by 2011, 3077; A 2017, 2522; 2021, 1662)
Nevada Legal Code